대한임상검사과학회지 (Korean Journal of Clinical Laboratory Science)

  • 제50권3호
  • /
  • Pages.275-283
  • /
  • 2018
  • /
  • 1738-3544(pISSN)
  • /
  • 2288-1662(eISSN)
대한임상검사과학회 (Korean Society for Clinical Laboratory Science)
권호 표지
DOI QR코드

DOI QR Code

Zerumbone 처리에 따른 Helicobacter pylori의 단백질 비교분석

Comparative Proteome Analysis of Zerumbone-treated Helicobacter pylori

  • Kim, Sa-Hyun (Department of Clinical Laboratory Science, Semyung University)
  • 투고 : 2018.08.11
  • 심사 : 2018.08.30
  • 발행 : 2018.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Helicobacter pylori는 만성 위염, 위궤양 또는 위 선암을 비롯한 다양한 위장병의 원인균으로 알려져 있으며, 이 세균이 분비하는 cytotoxin-associated protein A (CagA), vacuolating cytotoxic protein A (VacA)와 같은 병원성 인자가 그 원인으로 알려져 있다. 본 연구에서는 zerumbone이 CagA, VacA를 비롯한 다양한 H. pylori의 병원성 인자들의 단백 발현양 변화에 정성적, 정량적으로 어떠한 영향을 미치는지 분석하였다. H. pylori 60190 (VacA 양성 / CagA 양성; Eastern type) 표준균주를 대상으로 하여 약 200개의 유의미한 단백을 선별한 후, 그 중에서 임상적으로 의의가 큰 13개 단백 분자에 대한 프로테옴 분석을 수행하였다. 이차원 전기 영동법(2 dimensional electrophoresis, 2-DE) 수행 후, 단백질 스팟의 정량적 측정에는 ImageMasterTM 2-DE Platinum 소프트웨어를 사용하였고, 단백 동정에는 matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-TOF-MS)와 liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS)를 사용하였다. 동정이 완료된 전체 단백 중에서 유의미한 변화를 보인 단백을 집중적으로 분석한 뒤에 필요에 따라 reverse transcription -polymerase chanin reaction을 수행하여 결과를 추가 검증하였다. 본 연구에서는 zerumbone이 보유한 새로운 약리학적 활성 기전을 스크리닝함으로써 향후 zerumbone이 H. pylori 감염증 치료제로서 어떠한 의미를 지니는지 규명하고자 하였다.

Helicobacter pylori is a causative organism of various gastrointestinal diseases, including chronic gastritis, gastric ulcer, or gastric adenocarcinoma. Pathogenic factors, such as cytotoxin-associated protein A (CagA) and vacuolating cytotoxic protein A (VacA), play a role. This study analyzed qualitatively and quantitatively the effects of zerumbone on the changes in the protein expression levels of various H. pylori proteins, including CagA and VacA. Approximately 200 significant proteins were screened for the H. pylori 60190 (VacA positive / CagA positive; Eastern type) strain, and proteomic analysis was performed on 13 protein molecules that were clinically significant. After two-dimensional electrophoresis (2-DE), $ImageMaster^{TM}$ 2-DE Platinum software was used for quantitative measurements of protein spots. Matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-TOF-MS) and liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) were used for protein identification. After intensive analysis of the proteins that showed significant changes, a reverse transcription-polymerase chain reaction was performed as required to verify the results. In this study, the significance of zerumbone as a therapeutic agent for H. pylori infection was examined by screening a new pharmacological activity mechanism of zerumbone.

키워드

참고문헌

  1. Cover TL, Cao P, Lind CD, Tham KT, Blaser MJ. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun. 1993;61:5008-5012.
  2. Israel DA, Salama N, Arnold CN, Moss SF, Ando T, Wirth HP. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest. 2001;107:611-620. https://doi.org/10.1172/JCI11450
  3. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem. 2000;275:16064-16072. https://doi.org/10.1074/jbc.M000959200
  4. Selbach M, Moese S, Meyer TF, Beckert S. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun. 2002;70:665-671. https://doi.org/10.1128/IAI.70.2.665-671.2002
  5. Megraud F, Neman-Simha V, Brugmann D. Further evidence of the toxic effect of ammonia produced by Helicobacter pylori Urease on human epithelial cells. Infect Immun. 1992;60: 1858-1863.
  6. Doig P, Austin JW, Kostrzynska M, Trust TJ. Production of a conserved adhesin by the human gastroduodenal pathogen Helicobacter pylori. J Bacteriol. 1992;174:2539-2547. https://doi.org/10.1128/jb.174.8.2539-2547.1992
  7. Waidner B, Greiner S, Odenbreit S, Kavermann H, Velayudhan J, Stahler F, et al. Essential role of ferritin Pfr in Helicobacter pylori iron metabolism and gastric colonization. Infect Immun. 2002;70:3923-3929. https://doi.org/10.1128/IAI.70.7.3923-3929.2002
  8. Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 1999;397:176-180. https://doi.org/10.1038/16495
  9. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997;388:539-547. https://doi.org/10.1038/41483
  10. Perimal EK, Akhtar MN, Mohamad AS, Khalid MH, Ming OH, Khalid S, et al. Zerumbone-induced antinociception: involvement of the L-arginine-nitric oxide-cGMP -PKC-K+ ATP channel pathways. Basic Clin Pharmacol Toxico. 2011;108:155-162. http://dx.doi.org/10.1111/j.1742-7843.2010.00635.x.
  11. Keong YS, Alitheen NB, Mustafa S, Abdul Aziz S, Abdul Rahman M, Ali AM. Immunomodulatory effects of zerumbone isolated from roots of Zingiber zerumbet. Pak J Pharm Sci. 2010;23: 75-82.
  12. Taha MM, Abdul AB, Abdullah R, Ibrahim TA, Abdelwahab SI, Mohan S. Potential chemoprevention of diethylnitrosamine- initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet). Chem Biol Interact. 2010;186: 295-305. http://dx.doi.org/10.1016/j.cbi.2010.04.029.
  13. Lee MH, Kim SH, Ryu SR, Lee P, Moon C. Enhancing the effects of Zerumbone on THP-1 cell activation. Korean J Clin Lab Sci. 2017;49:1-7. https://doi.org/10.15324/kjcls.2017.49.1.1.
  14. Yuan F, Bai G, Chen Y, Miao Y, Chen J, Li X. Structure-activity relationships of diverse ACGs against multidrug resistant human lung cancer cell line A549/Taxol. Bioorg Med Chem Lett. 2015;25:787-790. https://doi.org/10.1016/j.bmcl.2014.12.088.
  15. Choi SH, Lee YJ, Seo WD, Lee HJ, Nam JW, Lee YJ, et al. Altered cross-linking of HSP27 by zerumbone as a novel strategy for overcoming HSP27-mediated radioresistance. Int J Radiat Oncol Biol Phys. 2011;79:1196-1205. https://doi.org/10.1016/j.ijrobp.2010.10.025.
  16. Woo HJ, Lee MH, Yang JY, Kwon HJ, Yeon MJ, Kim DH, et al. Evaluation of urease inhibition activity of zerumbone in vitro. Microbiol. Biotechnol. Lett. 2017;45:265-270. http://dx.doi.org/10.4014/mbl.1708.08002.
  17. Yoo TH, Lee MH, Park M, Lee J, Woo HJ, Kim HW, et al. Detection of EBV-encoded small RNA from diffuse large B-cell lymphoma patients by RT-PCR method. Biomedical Science Letters. 2015;21:227-232. https://doi.org/10.15616/BSL.2015.21.4.227.
  18. Kim SH, Lee MH, Park M, Woo HJ, Kim YS, Tharmalingam N, et al. Regulatory effects of black rice extract on Helicobacter pylori infection-induced apoptosis. Mol Nutr Food Res. 2018;62. https://doi.org/10.1002/mnfr.201700586.
  19. Jungblut PR, Bumann D, Haas G, Zimmy-Arndt U, Holland P, Lamer S, et al. Comparative proteome analysis of Helicobacter pylori. Mol Microbiol. 2000;36:710-725.
  20. Park JW, Song JY, Lee SG, Jun JS, Park JU, Chung MJ, et al. Quantitative analysis of representative proteome components and clustering of Helicobacter pylori clinical strains. Helicobacter. 2006;11:533-543. https://doi.org/10.1111/j.1523-5378.2006.00456.x
  21. Backert S, Kwok T, Schmid M, Selbach M, Moese S, Peek RM Jr, et al. Subproteomes of soluble and structure-bound Helicobacter pylori proteins analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proteomics. 2005;5:1331-1345. https://doi.org/10.1002/pmic.200401019
  22. Kim SH. Comparative proteome analysis of celastrol-treated Helicobacter pylori. Biomedical Science Letters. 2017;23:395-401. https://doi.org/10.15616/BSL.2017.23.4.395
  23. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. cag, a pathogenicity island of Helicobacter pylori encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA. 1996;93:14648-14653. https://doi.org/10.1073/pnas.93.25.14648
  24. Rassow J. Helicobacter pylori vacuolating toxin A and apoptosis. Cell Commun Signal. 2011;9:26. https://doi.org/10.1186/1478-811X-9-26.
  25. Kim SH, Kim JB. Comparative proteome analysis of cyanidin 3-O-glucoside treated Helicobacter pylori. Biomedical Science Letters. 2015;21:233-240. https://doi.org/10.15616/BSL.2015.21.4.233.
  26. Skouloubris S, Labigne A, De Reuse H. The AmiE aliphatic amidase and AmiF formamidase of Helicobacter pylori natural evolution of two enzyme paralogues. Mol Microbiol. 2001;40:596-609. https://doi.org/10.1046/j.1365-2958.2001.02400.x
  27. Gilbreath JJ, West AL, Pich OQ, Carpenter BM, Michel S, Merrell DS. Fur activates expression of the 2-oxoglutarate oxidoreductase genes (oorDABC) in Helicobacter pylori. J Bacteriol. 2012;194:6490-6497. https://doi.org/10.1128/JB.01226-12.

피인용 문헌

  1. Zerumbone Inhibits Helicobacter pylori Urease Activity vol.26, pp.9, 2021, https://doi.org/10.3390/molecules26092663